Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.

PLoS One · 2016 · PMC5199102 · PMID 28033344

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Compared with patients in the lamivudine-resistant group, patients in the lamivudine-susceptible group had lower HBsAg levels at baseline (p<0.001) and at 48 weeks (p = 0.070), though the difference at week 48 did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.